Bengtsson Bostrom K, Hedner J, Grote L, Melander O, von Wowern F, Rastam L
Int J Hypertens. 2010; 2010.
PMID: 20948559
PMC: 2949080.
DOI: 10.4061/2010/458410.
Seedat Y, Randeree I
Clin Drug Investig. 2008; 16(3):229-40.
PMID: 18370544
DOI: 10.2165/00044011-199816030-00007.
Jackson R
BMJ. 2000; 320(7236):659-61.
PMID: 10710556
PMC: 1117692.
DOI: 10.1136/bmj.320.7236.659.
Kawachi I
Pharmacoeconomics. 1992; 2(4):324-34.
PMID: 10147045
DOI: 10.2165/00019053-199202040-00007.
Avanzini F, Tognoni G, Alli C, Colombo F, Herxheimer A
Eur J Clin Pharmacol. 1996; 49(6):445-50.
PMID: 8706768
DOI: 10.1007/BF00195929.
Community control of hypertension at work-site: epidemiological data of the Agusta project.
Fogari R, Marasi G, Zoppi A, Malamani G, Vanasia A, Villa G
Eur J Epidemiol. 1995; 11(5):591-5.
PMID: 8549736
DOI: 10.1007/BF01719314.
High blood pressure and the incidence of non-insulin dependent diabetes mellitus: findings in a 11.5 year follow-up study in The Netherlands.
Stolk R, van Splunder I, Schouten J, Witteman J, Hofman A, Grobbee D
Eur J Epidemiol. 1993; 9(2):134-9.
PMID: 8519350
DOI: 10.1007/BF00158782.
Pharmacokinetic drug interactions with ACE inhibitors.
Shionoiri H
Clin Pharmacokinet. 1993; 25(1):20-58.
PMID: 8354016
DOI: 10.2165/00003088-199325010-00003.
Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.
Fulton B, Wagstaff A, Sorkin E
Drugs. 1995; 49(2):295-320.
PMID: 7537194
DOI: 10.2165/00003495-199549020-00011.
Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy.
Morisco C, Argenziano L, Tozzi N, Mele A, Ricciardelli B, Condorelli G
Drugs. 1993; 46 Suppl 2:88-94.
PMID: 7512489
DOI: 10.2165/00003495-199300462-00016.
General considerations when treating hypertension.
Hansson L
Drugs. 1993; 46 Suppl 2:37-9.
PMID: 7512480
DOI: 10.2165/00003495-199300462-00008.
Overview and perspectives of antihypertensive treatment.
Zanchetti A
Drugs. 1990; 40 Suppl 4:85-91.
PMID: 2151185
DOI: 10.2165/00003495-199000404-00027.
Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
Dahlof C, Hedner T, Thulin T, Gustafsson S, Olsson S
Eur J Clin Pharmacol. 1991; 40(5):453-60.
PMID: 1884720
DOI: 10.1007/BF00315222.
New approaches to the treatment of hypertension.
Kaplan N
Cardiovasc Drugs Ther. 1991; 5(6):973-8.
PMID: 1801895
DOI: 10.1007/BF00143522.
Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs.
Andersson R, Karlberg B, Lindgren B, Persson K, Rosenqvist U
Drugs. 1991; 41 Suppl 1:48-53.
PMID: 1712272
DOI: 10.2165/00003495-199100411-00009.
General well-being during treatment with different ACE-inhibitors: two double-blind placebo-controlled cross-over studies in healthy volunteers.
Dahlof C, Dimenas E
Eur J Clin Pharmacol. 1992; 43(4):375-9.
PMID: 1451716
DOI: 10.1007/BF02220612.
